Kaposi's sarcoma in a different concept from HIV-AIDS: report of a case in a patient with Behçet's disease and immunomodulatory drugs

Diego Mendoza Contreras; Jose Maria Zepeda Torres; Grecia Jazmín García Gutiérrez; Félix Osuna Gutiérrez; Larissa Michelle Navarro Soberanes

doi:10.18203/2319-2003.ijbcp20222064

Authors

Diego Mendoza Contreras Hospital General Regional No. 1 “Lic. Ignacio García Téllez”, Mérida, Yucatán, México
Jose Maria Zepeda Torres Universidad Autónoma de Guadalajara, Guadalajara, Jalisco, México
Grecia Jazmín García Gutiérrez Hospital General Regional No. 1 “Lic. Ignacio García Téllez”, Mérida, Yucatán, México
Félix Osuna Gutiérrez Universidad Autónoma de Guadalajara, Guadalajara, Jalisco, México
Larissa Michelle Navarro Soberanes Universidad Autónoma de Guadalajara, Guadalajara, Jalisco, México

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20222064

Keywords:

Behçet's disease, Immunomodulatory drugs, Case report

Abstract

Kaposi's sarcoma (KS) is a malignant vascular neoplasm that typically appears opportunistically in patients with acquired immunodeficiency syndrome (AIDS); it can also arise in organ transplanted subjects and exceptionally in carriers of autoimmune diseases, such as Behçet's disease. A 23-year-old man with Behçet's disease who debuts with clinically and histologically compatible dermatosis with KS. Conclusions. KS is not exclusive to HIV-AIDS, it also prevails in situations of primary or secondary immunocompromision that favor its appearance, as is the case of Behçet's Disease and its immunomodulatory therapy.

Metrics

Metrics Loading ...

References

Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013;137(2):289-94.

James ND, Stewart JS. Kaposi's sarcoma and AIDS. Int J STD AIDS. 1991;2(2):91-6.

Louthrenoo W, Kasitanon N, Mahanuphab P, Bhoopat L, Thongprasert S. Kaposi's sarcoma in rheumatic diseases. Semin Arthritis Rheum. 2003;32(5):326-33.

Etemad SA, Dewan AK. Kaposi Sarcoma Updates. Dermatol Clin. 2019;37(4):505-17.

Dupin N. Update on oncogenesis and therapy for Kaposi sarcoma. Curr Opin Oncol. 2020;32(2):122-8.

Rappersberger K, Stingl G, Wolff K. Kaposi’s sarcoma. In: Freedberg IM, Sisen AZ, Wolff K et al. Fitzpatrick’s Dermatology in General Medicine, 5th ed. New York, McGrawHill. 1999;1195-204.

Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865-9.

Mariggiò G, Koch S, Schulz TF. Kaposi sarcoma herpesvirus pathogenesis. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160275.

Rady PL, Hodak E, Yen A, Memar O, Trattner A, Feinmesser M et al. Detection of human herpes virus-8 DNA in Kaposi’s sarcoma from iatrogenically immunosuppressed patients. J Am Acad Dermatol. 1998;38:429-37.

Wen KW, Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 2010;289(2):140-50.

Mezalek ZT, Harmouche H, Attar NE, Serraj K, Aouni M, Adnaoui M, Maaouni A. Kaposi's sarcoma in association with Behcet's disease: case report and literature review. Semin Arthritis Rheum. 2007;36(5):328-31.